BBIO logo

BridgeBio Pharma, Inc. (BBIO) Total Expenses

Annual Total Expenses:

$799.27M+$190.52M(+31.30%)
December 31, 2024

Summary

  • As of today, BBIO annual total expenses is $799.27 million, with the most recent change of +$190.52 million (+31.30%) on December 31, 2024.
  • During the last 3 years, BBIO annual total expenses has risen by +$152.92 million (+23.66%).
  • BBIO annual total expenses is now at all-time high.

Performance

BBIO Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

Quarterly Total Expenses:

$303.44M+$10.97M(+3.75%)
September 30, 2025

Summary

  • As of today, BBIO quarterly total expenses is $303.44 million, with the most recent change of +$10.97 million (+3.75%) on September 30, 2025.
  • Over the past year, BBIO quarterly total expenses has increased by +$138.67 million (+84.16%).
  • BBIO quarterly total expenses is now at all-time high.

Performance

BBIO Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

BBIO Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+31.3%+84.2%
3Y3 Years+23.7%+120.4%
5Y5 Years+160.5%+144.7%

BBIO Total Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+46.4%at high+301.3%
5Y5-Yearat high+160.5%at high+301.3%
All-TimeAll-Timeat high+1722.4%at high+1042.9%

BBIO Total Expenses History

DateAnnualQuarterly
Sep 2025
-
$303.44M(+3.8%)
Jun 2025
-
$292.47M(+3.0%)
Mar 2025
-
$284.06M(+4.8%)
Dec 2024
$799.27M(+31.3%)
$270.93M(+64.4%)
Sep 2024
-
$164.77M(+117.9%)
Jun 2024
-
$75.62M(-69.3%)
Mar 2024
-
$246.34M(+45.0%)
Dec 2023
$608.75M(+11.5%)
$169.89M(-6.2%)
Sep 2023
-
$181.09M(+13.5%)
Jun 2023
-
$159.54M(+12.4%)
Mar 2023
-
$141.98M(+1.8%)
Dec 2022
$546.09M(-15.5%)
$139.46M(+1.3%)
Sep 2022
-
$137.68M(+64.7%)
Jun 2022
-
$83.60M(-57.8%)
Mar 2022
-
$198.09M(+23.8%)
Dec 2021
$646.35M
$160.06M(+1.1%)
DateAnnualQuarterly
Sep 2021
-
$158.28M(+5.3%)
Jun 2021
-
$150.37M(-8.1%)
Mar 2021
-
$163.54M(+36.2%)
Dec 2020
$482.73M(+57.3%)
$120.10M(-3.1%)
Sep 2020
-
$123.99M(+2.4%)
Jun 2020
-
$121.03M(+31.8%)
Mar 2020
-
$91.85M(+5.2%)
Dec 2019
$306.80M(+67.0%)
$87.28M(+0.6%)
Sep 2019
-
$86.72M(+31.5%)
Jun 2019
-
$65.96M(+7.8%)
Mar 2019
-
$61.19M(+94.9%)
Dec 2018
$183.66M(+318.8%)
-
Sep 2018
-
$31.40M(+18.3%)
Jun 2018
-
$26.55M(-22.3%)
Mar 2018
-
$34.16M
Dec 2017
$43.86M
-

FAQ

  • What is BridgeBio Pharma, Inc. annual total expenses?
  • What is the all-time high annual total expenses for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. annual total expenses year-on-year change?
  • What is BridgeBio Pharma, Inc. quarterly total expenses?
  • What is the all-time high quarterly total expenses for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. quarterly total expenses year-on-year change?

What is BridgeBio Pharma, Inc. annual total expenses?

The current annual total expenses of BBIO is $799.27M

What is the all-time high annual total expenses for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high annual total expenses is $799.27M

What is BridgeBio Pharma, Inc. annual total expenses year-on-year change?

Over the past year, BBIO annual total expenses has changed by +$190.52M (+31.30%)

What is BridgeBio Pharma, Inc. quarterly total expenses?

The current quarterly total expenses of BBIO is $303.44M

What is the all-time high quarterly total expenses for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high quarterly total expenses is $303.44M

What is BridgeBio Pharma, Inc. quarterly total expenses year-on-year change?

Over the past year, BBIO quarterly total expenses has changed by +$138.67M (+84.16%)
On this page